Diabetic Macular Edema Treatment with Bevacizumab Does Not Depend on the Retinal Nonperfusion Presence
This study evaluated the relationship between the retinal nonperfusion area (NPA) presence and the effectiveness of bevacizumab treatment (IVB) in patients with diabetic macular edema (DME). It also tested the prognostic usefulness of ultra-wide-field fluorescein angiography (UWFFA) and OptosAdvance...
Saved in:
Main Authors: | Bogumiła Sędziak-Marcinek, Sławomir Teper, Elżbieta Chełmecka, Adam Wylęgała, Mateusz Marcinek, Mateusz Bas, Edward Wylęgała |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2021/6620122 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography
by: Magdalena Hunt, et al.
Published: (2022-01-01) -
Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
by: Tatsuya Yunoki, et al.
Published: (2013-01-01) -
Five-Year Follow-Up of Repeated Intravitreal Bevacizumab for Macular Edema in a Pediatric Patient with Retinal Arteriovenous Malformation and Excellent Vision
by: Andrew R. Miller, et al.
Published: (2023-01-01) -
Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion
by: Manish Nagpal, et al.
Published: (2011-01-01) -
Pengaruh Bevacizumab Intravitreal terhadap Best Corrected Visual Acuity dan Central Macular Thickness pada Diabetic Macular Edema
by: Arini Ghaisa Atsari, et al.
Published: (2020-01-01)